Pharsight

Drugs that contain Leniolisib Phosphate

1. Joenja patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8653092 PHARMING Tetrahydro-pyrido-pyrimidine derivatives
Feb, 2032

(7 years from now)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity (ODE) Mar 24, 2030
New Chemical Entity Exclusivity (NCE) Mar 24, 2028

NCE-1 date: 2027-03-25

Market Authorisation Date: 24 March, 2023

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage

JOENJA family patents

Family Patents